This decrease in antigen presentation capacity, together with suppression of the adaptive and the innate immune systems by TGF-β could lead to enhanced immune evasion not only against viral but also tumor antigens in the wake of glioblastoma CMV infection. The gene discussed is TGFB1; the disease is glioblastoma.